Consolidated Statements of Cash Flows $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Operating activities:
Net Income (Loss) From Continuing Operations	$ (3,078)	$ (140)	$ (317)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	126	115	92
Intangible asset amortization	281	280	281
Noncash lease expense	7	11	13
Financing fee and premium amortization	2	0	(2)
Share-based compensation expense	19	76	139
(Gain) loss from change in fair value of financial instruments	(1)	(57)	10
(Gain) Loss from change in fair value of tax receivable agreement	(93)	34	118
Release of unrecognized tax provision	0	(1)	(1)
Deferred tax expense (benefit)	8	(19)	(9)
Goodwill impairment	3,124	0	0
Other	15	(1)	2
Changes in operating assets and liabilities:
Accounts receivable	84	(37)	(20)
Accounts payable and accrued liabilities	(90)	31	(61)
Other assets and liabilities	(44)	(99)	2
Cash provided by operating activities - continuing operations	360	193	247
Cash provided by operating activities - discontinued operations	0	59	139
Net cash provided by operating activities	360	252	386
Investing activities:
Net proceeds from sale of business	(13)	968	0
Acquisition of businesses, net of cash acquired	0	0	1
Capital expenditures	(110)	(121)	(140)
Cash provided by (used in) investing activities - continuing operations	(123)	847	(139)
Cash used in investing activities - discontinued operations	0	(11)	(20)
Net cash provided by (used in) investing activities	(123)	836	(159)
Financing activities:
Dividend payments	(86)	(21)	0
Net increase (decrease) in fiduciary liabilities	9	5	(21)
Repayments to banks	(20)	(765)	(25)
Principal payments on finance lease obligations	(22)	(27)	(25)
Payments on tax receivable agreements	(100)	(62)	(7)
Tax payment for shares/units withheld in lieu of taxes	(12)	(59)	(16)
Deferred and Contingent Consideration Payments	0	0	(9)
Repurchase of shares	(65)	(167)	(40)
Other financing activities	(2)	0	(1)
Cash used for financing activities - continuing operations	(298)	(1,096)	(144)
Cash provided by (used in) financing activities - discontinued operations	0	22	(87)
Net Cash provided by (used in) financing activities	(298)	(1,074)	(231)
Effect of exchange rate changes on cash, cash equivalents and restricted cash - continuing operations	0	1	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash - discontinued operations	0	(3)	4
Net increase (decrease) in cash, cash equivalents and restricted cash	(61)	12	0
Cash, cash equivalents and restricted cash balances from:
Continuing operations - beginning of year	582	558	482
Discontinued operations - beginning of year	0	1,201	1,277
Less discontinued operations - end of period	0	0	1,201
Less fiduciary cash transferred with sale of business	0	1,189	0
Continuing operations - end of period	521	582	558
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	273	343	324
Restricted cash included in fiduciary assets	248	239	234
Total cash, cash equivalents and restricted cash	521	582	558
Supplemental disclosures:
Interest paid	94	108	128
Income taxes paid	36	50	46
Supplemental disclosure of non-cash investing and financing activities:
Fixed asset additions acquired through finance leases	8	62	12
Right of use asset additions acquired through operating leases	$ 9	$ 8	$ 3